Human HSA-CML Control Peptide

  • Catalog number
    CML001-P1
  • Price
    Please ask
  • Size
    1.8 mg
  • Availability
    Please contact us to check the availability
  • Immunogen
    Human Serum albumin (HSA) synthetically modified at Lysine residues and converted to HSA-N(epsilon)-(Carboxymethyl)-Lysine
  • Specificity
    CML-HSA will be bound by most polyclonal AGE-antibodies and CML-specific monoclonal antibodies.
  • Species reactivity
    -
  • Product presentation
    Protein solution (HSA-CML) dialysed against PBS, 0.08% NaN3** added
  • Product category
    Control Peptide
  • Antibody s raised in
    Human
  • Antibody s isotype
    -
  • Antibody s clone
    -
  • Product is supplied as
    liquid concentrate
  • Recommended concentration for use
    1-100 µg/ml
  • Protein concentration
    18 mg/ml
  • Positive control
    -
  • Pretreatment
    -
  • Tested applications
    IHC control, ELISA, WB, PAGE,
  • Recommended secondary reagent
    none
  • Storage method
    Store at -20°C
  • UniProt number
    Go to UniProt/SwissProt
  • Litterature
    1. Kilhovd B.K., Giardino I., Torjesen P.A., Birkeland K.I., Berg, T.J., Thornally P.J., Brownlee M., and Hanssen K.F. (2003) Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimmidazolone in patiens with type 2 diabetes. Metabolism 52(2); 163-167. 2. Cellek S., Qu W., Schmidt A.M., and Moncada S. (2004) Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic neuropathy in diabetes. Diabetologia 47(2); 331-339.
  • Tips
    *Gentaur products are intended for in vitro research use only. They must not be used for clinical diagnostics and not for in vivo experiments in humans or animals.
  • Description
    Isotype or positive controls by peptides, antibodies and deactivated samples. Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.
  • Properties
    Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.
  • Gene target
  • Gene symbol
    BCR, MIR3591, MIR3150A, MIR146A, MIR374A, MIR18A, MIR323B, MIR301A, MIR148A, MIR193A
  • Short name
    AGE
  • Technique
    Control, peptide, controls, peptides
  • Species
    Human, Humans
  • Alternative name
    HSA-CML
  • Alternative technique
    peptides, controls
  • Tissue
    control
Gene info
  • Identity
  • Gene
    BCR
  • Long gene name
    BCR activator of RhoGEF and GTPase
  • Synonyms gene
  • Synonyms gene name
    • breakpoint cluster region
    • BCR, RhoGEF and GTPase activating protein
  • Synonyms
  • Locus
  • Discovery year
    1986-01-01
  • Entrez gene record
    613
  • Pubmed identfication
  • RefSeq identity
  • Classification
    • C2 domain containing
    • My-T-BRC complex
    • Dbl family Rho GEFs
    • Pleckstrin homology domain containing
  • VEGA ID
  • Locus Specific Databases
Gene info
Gene info
Gene info
Gene info
Gene info
Gene info
Gene info
Gene info
Gene info
Product images
Similar products
Filters
Contact
Chat with gentaur.com employee